Yongxiang Song

机构：Zunyi Medical University, Affiliated Hospital of Zunyi Medical College · ORCID：0000-0003-1022-0202

发表论文 54 篇 · 总被引 1086 次 · h-index 18

代表论文

• First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial (2023 · Nature Medicine · 被引 174)
• PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer (2023 · Nature Communications · 被引 67)
• Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer (2025 · Nature Communications · 被引 39)
• Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) (2024 · Journal of Thoracic and Cardiovascular Surgery · 被引 32)
• Roles of circRNAs in regulating the tumor microenvironment (2023 · Medical Oncology · 被引 23)
• Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study (2024 · Frontiers in Immunology · 被引 19)